Atlas Trials

The Effect of Switching the H1-antagonist Clemastine to Cetirizine in Premedication Regimens During Paclitaxel Treatment

Clinical trial NCT06039137 · COMPLETED

Trial details

NCT number
NCT06039137
Sponsor
Erasmus Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
Solid Tumor
Start date
2022-06-01
Primary completion
2023-04-27
Enrollment
395

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.